Ribavirin is effective against drug-resistant H7N9 influenza virus infections

Ribavirin is effective against drug-resistant H7N9 influenza virus infections

Bibliographic Details
Main Authors:	Yuhai Bi, Gary Wong, Yingxia Liu, Lei Liu, George F. Gao, Yi Shi
Format:	Article
Language:	English
Published:	SpringerOpen 2016-07-01
Series:	Protein & Cell
Online Access:	http://link.springer.com/article/10.1007/s13238-016-0287-0

Similar Items

Development of a quadruple qRT-PCR assay for simultaneous identification of highly and low pathogenic H7N9 avian influenza viruses and characterization against oseltamivir resistance
by: Yang Yang, et al.
Published: (2018-08-01)

Zika virus in the testes: should we be worried?
by: Gary Wong, et al.
Published: (2017-01-01)

Delayed peak of human infections and ongoing reassortment of H7N9 avian influenza virus in the newly affected western Chinese provinces during Wave Five
by: Jin Li, et al.
Published: (2019-11-01)

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
by: Jack T Nguyen, et al.
Published: (2010-01-01)

Avian-to-Human Receptor-Binding Adaptation of Avian H7N9 Influenza Virus Hemagglutinin
by: Ying Xu, et al.
Published: (2019-11-01)

Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
by: Jennifer Mayor, et al.
Published: (2021-06-01)

Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
by: Jack T Nguyen, et al.
Published: (2012-01-01)

Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
by: Justin D Hoopes, et al.
Published: (2011-01-01)

Mechanism of Ribavirin in Enhancement of the Action of IFN-α against Hepatitis C Virus
by: Wei-Liang Liu, et al.
Published: (2007)

Novel genetic reassortants in H9N2 influenza A viruses and their diverse pathogenicity to mice
by: Bi Yuhai, et al.
Published: (2011-11-01)

Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
by: Min Zhao, et al.
Published: (2018-08-01)

In vitro and in vivo activity of ribavirin against Andes virus infection.
by: David Safronetz, et al.
Published: (2011-01-01)

Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus.
by: Jin Il Kim, et al.
Published: (2020-12-01)

The Character of Influenza Virus the H7 Subtype and Alert to Novel Influenza Virus H7N9 Subtype Virus
by: NLP Indi Dharmayanti, et al.
Published: (2013-08-01)

Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus
by: Mutsumi Ito, et al.
Published: (2019-02-01)

Development of monoclonal antibodies against the neuraminidase of H7N9 influenza virus for diagnosis applications
by: Jhih-Shiang Dong, et al.
Published: (2016)

R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses
by: Katrina Sleeman, et al.
Published: (2013-09-01)

PCR for Detection of Oseltamivir Resistance Mutation in Influenza A(H7N9) Virus
by: Wei Wang, et al.
Published: (2014-05-01)

H7N9 Influenza Virus Containing a Polybasic HA Cleavage Site Requires Minimal Host Adaptation to Obtain a Highly Pathogenic Disease Phenotype in Mice
by: Mable Chan, et al.
Published: (2020-01-01)

Safe Pseudovirus-based Assay for Neutralization Antibodies against Influenza A(H7N9) Virus
by: Chao Qiu, et al.
Published: (2013-10-01)

Development of monoclonal antibodies against the hemagglutinin of influenza virus subtype H7N9 for diagnosis application
by: Jui Hsiao, et al.
Published: (2015)

Generation and application of monoclonal and polyclonal antibodies against hemagglutinin of H7N9 avian influenza virus
by: Yi-Wei Hong, et al.
Published: (2016-05-01)

Monitoring Avian Influenza A(H7N9) Virus through National Influenza-like Illness Surveillance, China
by: Cuiling Xu, et al.
Published: (2013-08-01)

Comparative Pathogenicity and Transmissibility of the H7N9 Highly Pathogenic Avian Influenza Virus and the H7N9 Low Pathogenic Avian Influenza Virus in Chickens
by: Hao Yu, et al.
Published: (2019-11-01)

The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus.
by: Xinjun Hu, et al.
Published: (2016-01-01)

Efficacy of Interferon α-2b and Ribavirin against West Nile Virus In Vitro
by: John F. Anderson, et al.
Published: (2002-01-01)

Generating and characterizing of mono- and polyclonal antibodies against hemagglutinin of avian H7N9 influenza A virus
by: Yi-Wei Hong, et al.
Published: (2017)

Sensitivity of a ribavirin resistant mutant of hepatitis C virus to other antiviral drugs.
by: Kathleen B Mihalik, et al.
Published: (2013-01-01)

Efficacy of Live-Attenuated H9N2 Influenza Vaccine Candidates Containing NS1 Truncations against H9N2 Avian Influenza Viruses
by: Sujuan Chen, et al.
Published: (2017-06-01)

Asymptomatic, Mild, and Severe Influenza A(H7N9) Virus Infection in Humans, Guangzhou, China
by: Zongqiu Chen, et al.
Published: (2014-09-01)

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
by: Masato Hatta, et al.
Published: (2018-10-01)

Comparative study between Ribavirin and Ribavirin plus Intravenous Immunoglobulin against Crimean Congo hemorrhagic fever
by: Hassan Salehi, et al.
Published: (2013-01-01)

HUMAN INFECTION WITH AVIAN INFLUENZA A (H7N9) VIRUS
by: Yi Zhang, et al.
Published: (2014-07-01)

Avian Influenza H7N9 Virus Adaptation to Human Hosts
by: Swan Tan, et al.
Published: (2021-05-01)

Selection of hepatitis C virus resistant to ribavirin
by: Feinstone Stephen M, et al.
Published: (2011-08-01)

Highly Pathogenic Avian Influenza A(H5N8) Virus in Wild Migratory Birds, Qinghai Lake, China
by: Mingxin Li, et al.
Published: (2017-04-01)

Ramsay Hunt Syndrome in a Patient with H7N9 Influenza Virus Infection
by: Jia-Jia Wang, et al.
Published: (2015-01-01)

Genetic and biological properties of H7N9 avian influenza viruses detected after application of the H7N9 poultry vaccine in China.
by: Xin Yin, et al.
Published: (2021-04-01)

Risk assessment of human infection with avian influenza A (H7N9) virus in Taiwan
by: Shu-Wan Jian, et al.
Published: (2014-07-01)

Entry properties and entry inhibitors of a human H7N9 influenza virus.
by: Youhui Si, et al.
Published: (2014-01-01)

Cannot write session to /tmp/vufind_sessions/sess_hibm4buq2h6ia12292lanvkc4h